Atlas Trials

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Clinical trial NCT02431481 · COMPLETED

Trial details

NCT number
NCT02431481
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Normal Renal FunctionImpaired Renal Function
Start date
2015-10-23
Primary completion
2017-09-14
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.